Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies, Inc. (UFPT) delivers innovative custom-engineered solutions for medical device manufacturers and industrial partners through advanced material science and precision manufacturing. This news hub provides investors and industry professionals with direct access to UFPT's official announcements and strategic developments.
Track all corporate communications including quarterly earnings, product innovation launches, and strategic partnerships. Our curated collection features regulatory filings, manufacturing process advancements, and market expansion updates essential for understanding UFPT's position in specialty packaging and component manufacturing.
Key updates cover medical sector innovations, new material applications, and OEM collaboration milestones. Stay informed about UFPT's patented technologies and engineering capabilities that drive solutions for minimally invasive surgery, implant packaging, and aerospace components.
Bookmark this page for real-time updates on UFPT's operational developments and industry leadership. Regularly refreshed content ensures you maintain current awareness of this critical supply chain partner's evolving market role.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the upcoming KeyBanc Capital Markets Healthcare Forum. The virtual event will feature presentations from the company's leadership, including Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille, scheduled for March 18, 2025, at 10:30 AM ET.
UFP Technologies (UFPT) reported record financial results for 2024, with net income rising 31.3% to $59.0 million and adjusted net income growing 32.5% to $67.6 million. Net sales increased 26.1% to $504.4 million compared to $400.1 million in 2023.
For Q4 2024, the company reported net income of $16.4 million (up 41.1%) and sales of $144.1 million (up 41.9%) compared to the same period in 2023. The company's MedTech segment showed particularly strong growth, with Q4 sales increasing 48.6% to $132.7 million and full-year sales rising 30.2% to $450.8 million.
CEO R. Jeffrey Bailly highlighted strong performance from newly acquired companies and noted expansion of operations in the Dominican Republic to accommodate business growth. The company anticipates two major programs launching in the second half of 2025 and expects strong cash flow to help reduce debt and position for future acquisitions.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical devices, sterile packaging, and engineered custom products, has announced its upcoming financial disclosure schedule. The company will release its fourth quarter and year-end 2024 financial results on Tuesday, February 25, 2025. This announcement pertains to the financial period ending December 31, 2024.
UFP Technologies (UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the CJS Securities 25th Annual "New Ideas for the New Year" Virtual Conference. The company's presentation is scheduled for January 14, 2025, at 8:45 AM ET.
Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille will represent the company at the conference, where they will present and host one-on-one investor meetings. The event provides an opportunity for investors to learn more about UFP Technologies' innovative designs and custom manufacturing capabilities in the medical sector.
UFP Technologies (UFPT) reported strong Q3 2024 results with net income increasing 40% to $16.4 million and sales growing 44% to $145.2 million compared to Q3 2023. The company's medical market sales rose 52.2% to $132.6 million, while gross margin improved to 28.6%. Organic sales growth was 9.7%, driven by strength in robotic surgery and infection prevention markets. Recent acquisitions performed above expectations, contributing $0.17 to EPS despite $3.1 million in increased interest expenses. The company's adjusted EBITDA increased 61.4% to $31.2 million in Q3 2024.
UFP Technologies, Inc. (Nasdaq: UFPT) has announced the acquisition of AQF Medical, a custom manufacturer of foam and thermoplastic components for medical devices and packaging. This marks UFP's fourth acquisition in recent months, expanding their MedTech platform and international presence. AQF Medical, headquartered in Navan, Ireland, with joint venture operations in Singapore, brings strategic value to UFP's global operations.
R. Jeffrey Bailly, Chairman and CEO of UFP Technologies, highlighted the acquisition's benefits, including an expanded European manufacturing presence and access to the Asian market. The companies share similar processes, materials, and clients, promising synergies and growth opportunities. Seamus Fagan, Managing Director of AQF Medical, expressed enthusiasm about joining UFP, anticipating mutual benefits for their worldwide client base.
UFP Technologies (UFPT) has announced its participation in the 15th Annual Midwest IDEAS Investor Conference, scheduled for August 28-29, 2024, in Chicago, IL. Chairman and CEO Jeffrey Bailly and CFO Ron Lataille will represent the company, with a presentation set for August 28 at 7:55 AM CT.
The event, hosted at The Gwen hotel, offers investors an opportunity to engage with UFPT executives through 1x1 meetings. The presentation will be webcast live and accessible via the conference website and UFP's investor relations page. This conference provides a platform for UFPT to showcase its business strategies and financial performance to potential investors and analysts in the Midwest region.
UFP Technologies (Nasdaq: UFPT) reported record Q2 2024 results, with net income of $13.6 million ($1.75 per diluted share), up from $11.9 million in Q2 2023. Sales increased 10.1% to $110.2 million. For the first half of 2024, net income reached $26.2 million on sales of $215.2 million.
The company completed three strategic acquisitions: Marble Medical, AJR Enterprises, and Welch Fluorocarbon, expected to add $90 million in revenue and $20 million in EBITDA. These acquisitions bring expertise in medical adhesives, patient handling, and thin film molding for implantable devices.
Q2 2024 highlights include:
- Medical market sales up 10.8% to $95.4 million
- Gross margin improved to 30.0%
- Operating income increased to $18.0 million
- Adjusted EBITDA grew 11.7% to $23.9 million
UFP Technologies (Nasdaq: UFPT) has acquired Marble Medical, a Tallahassee-based manufacturer of adhesive medical components and single-use devices. This strategic acquisition enhances UFP's capabilities in surgical robot drapes and stick to skin device platforms. Marble Medical's status as a 3M Preferred Converter and its precision die cutting expertise will broaden UFP's innovative solutions portfolio.
The acquisition aligns with UFP's focus on MedTech and is expected to provide valuable technologies in key markets. It also allows for vertical integration in existing application areas. Marble Medical's president, Joe Audie, expressed excitement about joining UFP, anticipating accelerated growth by leveraging their biocompatible adhesives expertise in areas such as diagnostic patches, wound care, and other stick to skin applications.
UFP Technologies (Nasdaq: UFPT) has announced the acquisition of Welch Fluorocarbon Inc., a Dover, New Hampshire-based company specializing in thermoformed and heat-sealed implantable medical device components. This strategic move enhances UFP's MedTech portfolio, adding significant thin film thermoforming capabilities.
R. Jeffrey Bailly, UFP's chairman and CEO, highlighted the complementary nature of Welch Fluorocarbon's expertise to UFP's existing thin film platform. The acquisition is expected to expand product development and manufacturing capabilities, allowing for more comprehensive client service. Bailly also noted the strong cultural fit between the two companies.
Kevin Wiley, Welch Fluorocarbon's Owner and CEO, expressed enthusiasm about joining UFP, citing the importance of having a partner that understands their rapidly expanding business and can support their growth potential.
